Sort
326,823 grants matching “clinical trial”
Clinical validity and utility of genomic targeted chemoprevention of PCa
$2,006,440Jianfeng Xu · Wake Forest University Health Sciences · UC2 · FY2010 · CA
Biology and Therapy of High Risk Neuroblastoma
$2,006,380Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2012 · CA
Quantitative systems biology of glioblastoma cells and their interactions with the neuronal and immunological milieu
$2,006,283Forest M White · Massachusetts Institute Of Technology · U54 · FY2023 · CA
Targeting sensory ganglia and glial signaling for the treatment of acute and chronic pain
$2,006,250Temugin Berta · University Of Cincinnati · R01 · FY2019 · NS
Center for Translational Viral Oncology (CTVO)
$2,006,137Krzysztof Reiss · Lsu Health Sciences Center · P20 · FY2019 · GM
SPORE: Brain Tumore SPORE Grant
$2,006,093Mitchel S. Berger · University Of California, San Francisco · P50 · FY2016 · CA
Clinical Training in Rheumatology
$2,005,975Daniel Kastner · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIE · FY2009 · AR
The Immunobiology of Marrow Allografts for Leukemia
$2,005,952Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
Coordinating Center for CALERIE
$2,005,824James Rochon · Duke University · U01 · FY2008 · AG
Surgery, Immunology and Immunotherapy of Human Cancer
$2,005,765Donald L Morton · Saint John'S Cancer Institute · P01 · FY2009 · CA
Improving the safety and efficacy of cell therapies
$2,005,762Malcolm K Brenner · Baylor College Of Medicine · U54 · FY2007 · HL
Center for Dietary Supplements and Inflammation
$2,005,567Prakash S. Nagarkatti · University Of South Carolina At Columbia · P20 · FY2012 · GM
Developing Information Infrastructure Focused on Cancer Comparative Effectiveness
$2,005,467David Alan Fenstermacher · H. Lee Moffitt Cancer Ctr & Res Inst · RC2 · FY2009 · CA
ACCORD
$2,005,398David C Goff · Wake Forest University Health Sciences · N01 · FY2009 · HL
Physical Fitness as an Objective Biomarker for AD/ADRD Risk Modification
$2,005,396Qing Zeng · George Washington University · RF1 · FY2020 · AG
An Open Source Research Permissions Framework for South Carolina
$2,004,583Jay Moskowitz · University Of South Carolina At Columbia · RC2 · FY2010 · LM
Race / Ethncicity, Hypertension and Prevention of VCID and Stroke after Intracerebral Hemmorrhage
$2,004,572Jonathan Rosand · Massachusetts General Hospital · R01 · FY2025 · NS
UCLA SPOTRIAS CENTER APPLICATION RENEWAL-PROGRAM PROJECT
$2,004,544Jeffrey L Saver · University Of California Los Angeles · P50 · FY2012 · NS
GHESKIO Clinical Trials Unit
$2,004,533Jean William Pape · Gheskio Center · UM1 · FY2022 · AI
Stroke Disparities Program
$2,004,423Chelsea M Kidwell · Georgetown University · U54 · FY2009 · NS
Vaccine Treatment and Evaluation Units: Phase I Schistosomiasis Vaccine Clinical Trial
$2,004,304Wendy Keitel · Baylor College Of Medicine · N01 · FY2017 · AI
A Controlled Clinical Trial of Regadenoson in Sickle Cell Anemia
$2,004,198David G. Nathan · Dana-Farber Cancer Inst · P50 · FY2016 · HL
Community-Based VCT: Zimbabwe
$2,004,140Stephen F Morin · University Of California, San Francisco · U01 · FY2008 · MH
THE COMPARATIVE EFFECTIVENESS OF TELEMEDICINE TO DETECT DIABETIC RETINOPATHY
$2,003,926Thomas Mark Becker · Oregon Health & Science University · U48 · FY2010 · DP
MOTOR-Maternal Oral Therapy to Reduce Obstetric Risk
$2,003,919University Of North Carolina Chapel Hill · U01 · FY2003 · DE